Key Takeaways
Understanding the inflammation-menopause connection empowers women to protect their long-term health through targeted interventions that address root causes rather than just symptoms.
• Declining estrogen triggers chronic inflammation: Menopause removes estrogen's powerful anti-inflammatory protection, causing inflammatory markers like CRP to rise significantly and creating widespread immune system activation.
• Visceral fat becomes an inflammatory factory: Menopausal weight gain, especially belly fat, produces inflammatory cytokines that create a dangerous feedback loop of inflammation and metabolic dysfunction.
• Multiple body systems suffer from uncontrolled inflammation: Chronic inflammation during menopause increases risks for heart disease, osteoporosis, dementia, and autoimmune conditions through interconnected pathways.
• Anti-inflammatory lifestyle changes show measurable results: Mediterranean diet, moderate exercise, quality sleep, and stress management can reduce inflammatory markers within 4-12 weeks when implemented consistently.
• Early intervention prevents long-term complications: Addressing inflammation proactively through combined approaches protects against serious health conditions that develop silently over years after menopause.
The key insight is that inflammation during menopause isn't inevitable - it's manageable through evidence-based strategies that target multiple pathways simultaneously. Women who understand this connection can take control of their health trajectory and significantly improve their quality of life during and after the menopausal transition.
Up to 85% of menopausal women experience symptoms like hot flashes, joint pain, and fatigue38, but many don't realize inflammation and menopause share a hidden connection. Declining estrogen levels during menopause trigger a cascade of chronic inflammation throughout the body2639. Estrogen has anti-inflammatory properties, and inflammatory markers like C-reactive protein increase by a lot when it decreases38. This process, known as inflammaging, accelerates during midlife and raises the risk of cardiovascular disease, osteoporosis, and autoimmune conditions26[-3]. Managing symptoms and protecting long-term health through anti-inflammatory strategies requires that you understand this connection.
The hidden link between inflammation and menopause
What happens during menopause
Menopause marks the permanent cessation of menstruation, confirmed after 12 consecutive months without a period. The average age for this transition falls between 45 and 51 years, with the process lasting around 7 years, though it can extend up to 14 years40. The transition unfolds in three distinct stages. Perimenopause begins 8 to 10 years before menopause when ovaries reduce estrogen production2. Women experience irregular periods and fluctuating hormone levels at this phase. The menopause stage itself is a single point in time, the 12-month mark without menstruation. Postmenopause follows and lasts for the remainder of a woman's life2.
Ovaries stop producing eggs and reduce their output of estrogen and progesterone during this transition3. This hormonal move affects every system in the body, from bone density to cardiovascular function. Women spend roughly one-third of their lives in the postmenopausal stage, a period marked by vulnerability to immune and metabolic dysfunction40.
How inflammaging accelerates during midlife
Inflammaging, a term coined in 2000, describes chronic, low-grade inflammation throughout the body that occurs with aging41. While aging brings some inflammatory changes, the menopausal transition contributes to increased systemic inflammation, whatever the age5.
The immune system becomes less efficient at controlling excess inflammation as women progress through menopause41. Declining ovarian hormones at the menopausal transition coincide with higher levels of circulating inflammatory markers, including interleukin-6 (IL-6), IL-4, IL-2, and tumor necrosis factor (TNF-α) in postmenopausal women40. These inflammatory cytokines signal widespread immune activation. The endocrine transition from estrogen cycling to estrogen decline triggers a persistent low-grade inflammatory state40. This inflammation then accelerates ovarian failure and creates a feedback loop. So the menopausal transition prompts an innate immune inflammatory response in female reproductive organs that propagates throughout the body40.
Research links this inflammaging process to arthritis, cardiovascular disease, diabetes, cancer, and Alzheimer's disease41. Synchronous to systemic inflammatory responses, the perimenopausal transition exhibits a decline in brain glucose metabolism, myelin catabolism, and reduction of brain white matter volume40. These changes associate with beta-amyloid deposition and altered neurological function.
The role of estrogen in controlling inflammation
Estrogen functions as a powerful anti-inflammatory hormone. Circulating estrogens target cells of monocyte lineage and reduce several aspects of the native immune response42. The surface of macrophages, white blood cells involved in inflammatory responses, contains abundant receptors for estradiol, progesterone, and testosterone26.
When inflammatory stimuli from microbes, damaged tissues, or activated lymphocytes reach macrophages, these cells acquire pro-inflammatory polarization, called M1. This rapid activation produces pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-12, and IL-23, along with chemokines like monocyte chemotactic protein-142. Estrogens interact with signaling pathways responsible for resolving this pro-inflammatory stage. They shorten the duration of inflammation and direct resolution toward an acquired deactivation stage (M2c phenotype), characterized by production of IL-10 and TGF-β42. These compounds restore tissue homeostasis through cell repair, proliferation, and angiogenesis.
The dramatic rise in inflammatory diseases among postmenopausal women stems from this loss of estrogenic protection42. The prevalence of conditions with strong inflammatory components, including osteoporosis, atherosclerosis, diabetes, and arthritis, increases after ovarian function ceases42. Radiographic osteoarthritis is three times more common among women aged 45-64 years compared to their male peers43. Estrogen receptors in joint tissues confirm this connection between inflammatory disease and ovarian hormone loss43.
Further evidence shows that hormone therapy can reverse some inflammatory changes. IL-4 and IL-2 levels increase with menopause but decrease with hormone treatment and show hormone dependence40. This protective effect extends to cardiovascular health, bone preservation, and brain function.
Why your body becomes more inflamed during menopause

Several interconnected mechanisms drive the inflammatory surge that characterizes menopause. These pathways operate at the same time and increase each other to create a persistent state of chronic inflammation.
Hormonal changes trigger inflammatory responses
The decline in estradiol and progesterone production changes immune cell function in a fundamental way. Macrophages, the white blood cells responsible for orchestrating inflammatory responses, contain abundant receptors for these three hormones26. Estradiol reprograms cytokines during reproductive years to provide stronger defense against infection and injury. Macrophages lose this regulatory guidance when hormone levels plummet and become pro-inflammatory. They damage tissues rather than protect them.
Declining ovarian hormones at the menopausal transition coincide with higher levels of circulating interleukin-6 (IL-6), IL-4, IL-2, and tumor necrosis factor (TNF-α) in postmenopausal women44. These inflammatory markers signal widespread immune activation. Keep in mind that hormone therapy can reverse some of these changes. Studies show that IL-4 and IL-2 levels decrease with hormone treatment, which confirms their hormone dependence44.
The menopausal transition prompts an innate immune inflammatory response in female reproductive organs that propagates to the brain and makes it more susceptible to damage44. This body-wide inflammatory cascade contributes to symptoms ranging from joint pain to brain fog.
Belly fat produces inflammatory cytokines
Weight gain during menopause isn't just about esthetics. The amount of centrally stored visceral adipose tissue in postmenopausal women can reach twice that of premenopausal women45. Postmenopausal women show two-fold higher concentrations of both visceral and subcutaneous adipose tissue compared to premenopausal women, but only visceral adipose tissue links to adverse health risks45.
Visceral fat is different from subcutaneous fat in a fundamental way. Visceral adipose tissue secretes high levels of inflammatory molecules directly into portal vein blood because of its metabolic activity46. Studies found that visceral fat produces interleukin-6 (IL-6), which relates to concentrations of C-reactive protein (CRP) throughout the body46. Small adipocytes remain insulin sensitive. Enlarged adipocytes, especially in the visceral abdominal region, associate with higher fasting insulin and glucose levels45. These hypertrophic adipocytes attract macrophages and create an inflammatory state characterized by secretion of many proinflammatory cytokines and adipokines.
So women transitioning through menopause experience increases in serum amyloid A (SAA), tissue plasminogen activator (tPA), and monocyte-chemotactic protein-1 by a lot47. The increase in intraabdominal fat relates positively with changes in SAA, CRP, tPA, and leptin, while relating negatively with adiponectin47. Adipokines like leptin and adiponectin were higher in postmenopausal women compared with premenopausal women by a lot48. This shift creates insulin resistance, which exacerbates inflammation further and raises risks for cardiovascular disease.
Changes in gut health and microbiome
Estradiol and progesterone improve epithelial barrier function in intestinal epithelial cells by upregulating tight junction proteins49. Intestinal permeability increases when these hormones decline. Studies in mice show that ovariectomy increases intestinal permeability49. Plasma progesterone levels during human pregnancy relate inversely with plasma lipopolysaccharide, a marker of microbial translocation49.
A study of 65 women showed that plasma intestinal fatty acid binding protein (IFAB), lipopolysaccharide binding protein (LBP), and soluble CD14 (sCD14) increased from pre- to post-menopause by a lot49. Lower plasma estradiol associated with higher IFAB and sCD14 levels. This evidence suggests that microbial translocation increases over the menopausal transition and relates to sex hormone changes49.
The oral and gut microbiota alterations during menopause contribute to inflammation50. Decreased estradiol levels can cause oral problems and alter certain oral bacteria51. Hormonal fluctuations create conditions favoring growth of certain bacterial types over others. Disruptions in gut microbiome balance link to increased risk of cardiovascular disease, osteoporosis, and metabolic disorders at the same time52. These microbiome changes can contribute to digestive issues and systemic inflammation that affects overall health.
Cellular senescence and aging factors
Cellular senescence refers to cells entering permanent growth arrest. The number of senescent cells increases with age53. Senescent cells accumulate and compromise healthy cells as the aging immune system becomes less efficient. This affects knowing how to withstand stress, recuperate from injuries, and maintain cognitive function53.
Senescent cells secrete pro-inflammatory mediators known as the senescence-associated secretory phenotype (SASP)54. The SASP has cytokines, growth factors, and proteases that impose biological effects on neighboring cells. These factors, which include IL-1α, IL-1β, IL-6, IL-8, and macrophage inflammatory proteins, induce uncontrolled proliferation and inflammation in paracrine and autocrine manner54.
Inflammation precedes senescence and predicts senescence onset better than telomere length55. Pro-inflammatory factors like IL-1β and TNF-α stimulate accumulation of reactive oxygen species (ROS), which accelerates deterioration in a synergistic way55. This creates a feedback loop where inflammation promotes senescence and senescent cells produce more inflammation. The strong correlation between lipids and immune senescence stems from adipose tissue producing pro-inflammatory immune cells that accelerate immune senescence55. This process, termed inflammsenescence, describes the heightened pro-inflammatory state during cellular aging55. Lifestyle interventions like exercise and anti-inflammatory diets can suppress cellular senescence by reducing inflammation55.
Common symptoms that signal chronic inflammation

You need to understand symptoms that go beyond typical menopausal complaints to recognize chronic inflammation during menopause. These signs often get dismissed as normal aging, yet they signal mechanisms that need attention.
Physical symptoms: joint pain, fatigue, and aches
Joint pain from chronic inflammation shows up as throbbing and aching sensations56. The discomfort gets worse in mornings and after periods of inactivity56. Morning stiffness lasting more than one hour distinguishes inflammatory conditions from degenerative arthritis, where stiffness resolves within 30 minutes57. This prolonged morning stiffness is a useful gage of inflammatory activity57.
Affected joints feel stiff and limit movement range. Hands may struggle to form fists or fully bend fingers56. The joint lining becomes inflamed and causes swelling, heat, and tenderness to touch56. Multiple joints become involved in the inflammatory process57.
Fatigue is a troubling feature that can surpass pain in severity57. This profound tiredness persists whatever amount of sleep you get58. Nonspecific systemic symptoms like fatigue and depression may show up weeks to months before discrete joint symptoms57. The exhaustion worsens after minimal physical or mental activity58. Rest fails to ease these symptoms58.
Cognitive and emotional symptoms
Brain fog shows up when inflammation affects cognitive function. People struggle with attention, memory, and coherent thought formation59. Inflammatory cytokines communicate peripheral inflammation to the brain and drive these cognitive symptoms60.
Experimental induction of inflammation in healthy subjects triggers fatigue, psychomotor slowing, mild cognitive confusion, memory impairment, anxiety, and mood deterioration60. These inflammation-induced symptoms look like features of depression60. Patients receiving therapeutic administration of interferon-alpha develop true major depressive episodes in up to 50% of cases60.
Inflammation targets brain activity related to staying alert61. Attentional processes become compromised and make sustained focus difficult59. Memory seems vulnerable, with people reporting catastrophic impairment59. Emotional regulation deteriorates and leads to increased crying and mood instability59. The brain's ability to process sensory information diminishes and causes feelings of being overwhelmed59.
Digestive and immune system changes
Inflammatory bowel symptoms include diarrhea, abdominal pain and cramping, blood in stool, and loss of appetite with unintended weight loss62. These symptoms vary depending on inflammation severity and location62. It's worth mentioning that people experience periods of active illness followed by remission62.
Joint pain and rashes can signal that inflammation exists outside the intestine63. Ongoing abdominal pain may indicate an IBD flare, intestinal blockage, or severe colon infection63. Urgent, explosive bowel movements that affect quality of life are red flags63.
Immune dysfunction shows up through frequent infections requiring antibiotics more than twice yearly64. Chronic sinus infections, recurrent ear infections, or repeated pneumonia episodes indicate impaired germ-fighting capacity64. Morning joint stiffness, extreme tiredness resembling flu symptoms, and muscle aches accompany immune system disorders64. Digestive issues that persist beyond two to four weeks need evaluation64.
Long-term health risks of unmanaged inflammation
Chronic inflammation during menopause creates a pathway toward serious health conditions that develop silently over years. Evidence from diverse sources supports inflammation's causal role in these diseases, yet many women remain unaware of these connections.
Heart disease and stroke risk
Inflammation stands as an independent risk factor for cardiovascular disease development11. A pooled analysis of over 160,000 patients showed the adjusted relative risk of stroke per 3-fold increase in CRP reached 1.2765. More striking, hsCRP proved a stronger predictor of recurrent myocardial infarction, stroke, and cardiovascular death than LDL cholesterol in 31,245 statin-treated patients66. Those with hsCRP above 2 mg/L faced quite high risks for recurrent events despite having LDL cholesterol levels below 70 mg/dL66.
The evidence linking inflammation to heart disease is compelling and practical67. Nearly half of all heart attacks and strokes happen in people who have none of the four modifiable risk factors: smoking, high blood pressure, high cholesterol, and diabetes67. Systematic reviews showed higher fibrinogen levels associated with increased risk of recurrent stroke (pooled RR, 1.26) and major vascular events (RR, 1.31)65. Inflammatory cytokines such as IL-1α, TNF-α, and IL-6 produce prothrombotic effects that include upregulation of tissue factor, increased fibrinogen expression, and increased platelet reactivity65.
Diets high in red and processed meat, refined grains and sugary beverages increase subsequent risk of heart disease by 46% and stroke risk by 28% compared to anti-inflammatory diets68.
Bone loss and osteoporosis
Research suggests that up to 20% of bone loss can happen during menopausal stages and approximately 1 in 10 women over age 60 suffer from osteoporosis worldwide69. Several immune and inflammatory diseases show an association between circulating high-sensitivity CRP level and bone mineral density70. Pro-osteoclastic cytokines, such as TNF-α and IL-6, are elevated in inflammatory conditions and local cytokine profile remains consistent with cytokines that modulate bone resorption70. The production of IL-1, IL-6, and TNF-α by peripheral blood monocytes associates positively with bone resorption or spinal bone loss in healthy pre- and postmenopausal women70.
Neuroinflammation and dementia
Approximately 6.9 million people in the U.S. have Alzheimer's disease9. Published evidence shows the role of many inflammatory processes in the brain that contribute toward dementia pathology7. Microglia trigger neuroinflammatory responses by releasing proinflammatory chemokines, cytokines, and reactive oxygen species when stimulated7. Chronic activation of glial cells increases with age and elevates production of beta-amyloid and tau proteins, the hallmarks of Alzheimer's disease15. Activation of microglia and astrocytes were associated with disrupted expression of fast sleep spindles in people without accumulation of beta-amyloid plaques, suggesting that sleep deficits and inflammation might be among the earliest warning signs15.
The inflammation feedback loop
A process of inflammation and tissue damage perpetuates through feedback mechanisms16. Inflammation escalates out of control when feedback loops break down17. Unresolved inflammation morphs into chronic inflammation18. This creates self-perpetuating cycles where inflammation promotes cellular damage, damaged cells produce more inflammatory signals, and the cycle intensifies without intervention through lifestyle changes, dietary modifications, or hormone therapy.
How to test and monitor inflammation
Testing provides objective data to confirm whether chronic inflammation drives menopausal symptoms. Blood tests measure specific biomarkers that reveal inflammation levels, though they cannot pinpoint the exact source or location.
Understanding CRP levels and ranges
C-reactive protein represents the most available inflammatory marker. The liver produces CRP in response to inflammation and releases it into the bloodstream1. Levels rise and fall depending on inflammatory activity, which makes CRP valuable for monitoring treatment effectiveness1.
Healthy individuals maintain CRP levels below 0.8-1.0 mg/dL1. High-sensitivity CRP (hs-CRP) offers more precise measurement at low concentrations for cardiovascular risk assessment1. The hs-CRP ranges stratify heart disease risk: below 1.0 mg/L indicates low risk, 1.0-3.0 mg/L signals moderate risk, and above 3.0 mg/L suggests high risk198.
Standard CRP interpretation follows clear thresholds. Levels below 3 mg/L indicate normal status in healthy adults19. Readings between 3-10 mg/L may reflect minor elevation from conditions like pregnancy, diabetes, obesity, or smoking20. Moderate elevation of 10-100 mg/L associates with autoimmune diseases, cancer, heart attack, or bronchitis19. Marked elevation of 100-500 mg/L signals acute bacterial infection, viral infection, or trauma19. Severe elevation above 500 mg/L almost exclusively indicates acute bacterial infection19.
Several factors influence CRP results beyond inflammation and include insomnia, depression, hormone replacement therapy, and sex1. Females have higher CRP levels than males1[211].
Other inflammatory markers
Erythrocyte sedimentation rate (ESR) measures how red blood cells settle in a test tube21. ESR responds less quickly than CRP to inflammatory changes22. Plasma viscosity (PV) tests blood thickness by calculating force needed to move plasma through a tube22. Neither PV nor ESR change as fast as CRP22.
Additional markers include interleukin-6, TNF-alpha, fibrinogen, and serum amyloid A23. These cytokines get tested outside research settings rarely due to cost and storage requirements23.
Tracking symptoms and progress
Monitoring inflammation requires baseline CRP testing and repeat measurements at 3-6 months intervals. Symptom tracking complements blood tests by recording changes in joint pain, fatigue, and brain fog. Decreasing CRP levels signal successful intervention124.
Reducing inflammation through diet, lifestyle, and treatment

Managing inflammation and menopause requires a multi-pronged approach that combines dietary changes, lifestyle modifications, and medical interventions.
Mediterranean diet and anti-inflammatory foods
The Mediterranean diet for menopause represents the gold standard for anti-inflammatory menopause nutrition6. This eating pattern emphasizes fruits, vegetables, whole grains, lean protein, and healthy fats like olive oil6. These whole foods deliver antioxidants that strengthen immune function and ward off chronic inflammation menopause triggers6. The diet limits saturated fat, trans fat, and refined carbohydrates that promote inflammation25. Fiber and antioxidants work together to reduce inflammation throughout the body25. Include berries, greens, nuts, and oily fish in your diet26.
Key supplements: omega-3, curcumin, and more
Omega-3 fatty acids show compelling evidence for reducing inflammatory markers10. The body metabolizes EPA and DHA into signaling molecules that block cytokine production10. A daily intake of 1.25-2.5 grams lowered IL-6 levels by 10-12% over four months10. Curcumin interferes with inflammatory pathways, and small trials show benefits for metabolic disorders and joint pain menopause symptoms10. Combined administration of curcumin and omega-3 proved more effective than single supplementation2728. Vitamin D supplementation at high doses may tamp down inflammation in autoimmune conditions10.
Exercise: the right amount matters
Moderate exercise during menopause mobilizes inflammation-countering T cells that improve muscle function29. A single 20-minute session of moderate treadmill exercise resulted in a 5% decrease in TNF-producing immune cells30. Population studies show that engaging in physical activity more than 22 times per month associated with a 37% reduction in lifted CRP31. Regular moderate aerobic activity and resistance training diminish inflammation, whereas excessive high-intensity exercise may have detrimental effects32. The metabolic benefits appear only with repeated bouts of activity over time29.
Sleep and stress reduction
Sleep after menopause functions as an active repair phase. Pro-inflammatory cytokines are modulated during deep and REM sleep, growth hormone supports tissue repair, and the brain clears metabolic waste4. Even modest sleep restriction increases inflammatory markers such as CRP and interleukin-64. Restorative sleep allows the body to regulate cortisol and release anti-inflammatory cytokines, helping reset the immune system12. Quality rest acts as a natural anti-inflammatory and lowers markers often lifted in chronic conditions12. Balanced blood sugar supports better sleep continuity and reduces inflammatory burden through improved metabolic stability4. Stress management proves vital, as chronic stress lifts sympathetic nervous system activity, decreasing vagal tone and raising inflammatory signaling4.
Body-identical HRT benefits
Body-identical HRT offers anti-inflammatory benefits often overlooked. Estradiol reprograms cytokines to work more effectively, whereas synthetic hormones behave differently and may promote inflammation26. Body-identical hormones mirror the body's natural structure and are derived from yam plant or soy33. These regulated products have passed rigorous safety checks, unlike compounded bioidentical hormones3433. Estrogen and testosterone both possess anti-inflammatory properties that modulate inflammatory responses and improve tissue healing35. Studies demonstrate that hormone therapy decreases IL-4 and IL-2 levels lifted during menopause26.
Realistic timeline for seeing results
Lifestyle improvements at 2-month intervals may reduce TNF-α, IL-17A, and IFN-γ, with daily activity making the greatest contribution13. Reductions in inflammatory markers like CRP can be observed within 4-12 weeks of adopting a strict anti-inflammatory diet14. Subjective improvements in mood, energy, and anxiety levels may begin within the first few weeks as blood sugar stabilizes14. Visible inflammation such as swelling and joint pain reduces from three to four weeks36. Long-term adherence over two to three months yields sustained improvements in metabolic health, lipids, hormones, and immunity36. Diet changes work best when implemented over three to six months rather than drastically37. Combined approaches addressing weight gain during menopause, insulin resistance, and sleep quality prove most effective13. Even 5-10% weight loss substantially reduces inflammation, especially when targeting visceral fat. Regular monitoring through CRP testing, symptom tracking for fatigue and brain fog, and waist measurements helps assess progress. Understanding that life after menopause benefits from addressing inflammaging through multiple interventions provides the foundation for protecting cardiovascular health and preventing osteoporosis.
Conclusion
Understanding the connection between inflammation and menopause enables women to take control of their health during this transition. Declining estrogen naturally triggers inflammatory responses, but lifestyle interventions work. An anti-inflammatory diet, regular moderate exercise, quality sleep, and stress management can substantially reduce inflammatory markers within weeks to months. Early intervention matters most. Women who address inflammation proactively through combined approaches protect themselves against cardiovascular disease and osteoporosis. They also guard against cognitive decline. Body-identical HRT offers additional anti-inflammatory benefits worth discussing with healthcare providers. The menopausal transition doesn't have to mean accepting chronic inflammation as inevitable.
FAQs
Q1. Can hormone specialists help manage menopause symptoms? Yes, endocrinologists and hormone specialists can effectively manage menopause symptoms including hot flashes, night sweats, sleep disturbances, memory issues, and mood changes through personalized treatment approaches.
Q2. What dietary changes help reduce inflammation during menopause? Focus on eating plenty of fruits and vegetables, choosing high-fiber whole grains, selecting plant-based proteins and lean meats, incorporating healthy fats like omega-3s, reducing sugar intake, and limiting alcohol consumption to naturally lower inflammation levels.
Q3. What are the warning signs of chronic inflammation in menopausal women? Common signs include persistent fatigue, brain fog, unexplained fever, joint stiffness and muscle pain, unexplained weight changes, frequent infections, and mood disturbances like anxiety and depression that don't resolve with typical interventions.
Q4. Which supplements support women during perimenopause? Omega-3 fatty acids, magnesium, probiotics, vitamin D, and curcumin can help fill nutritional gaps, reduce inflammation, and support hormone balance during perimenopause when taken under professional guidance.
Q5. How long does it take to see results from anti-inflammatory lifestyle changes? Most women notice improvements in energy and mood within 2-4 weeks, while measurable reductions in inflammatory markers like CRP typically occur within 4-12 weeks of consistently following an anti-inflammatory diet and lifestyle program.
References
[1] - https://medlineplus.gov/lab-tests/c-reactive-protein-crp-test/
[2] - https://my.clevelandclinic.org/health/diseases/21841-menopause
[3] - https://www.hopkinsmedicine.org/health/conditions-and-diseases/introduction-to-menopause
[4] - https://alignedmodernhealth.com/stress-sleep-and-the-inflammation-cycle/
[5] - https://academic.oup.com/jcem/article/110/11/e3566/8092155?rss=1
[6] - https://www.eatingwell.com/article/2061785/anti-inflammatory-mediterranean-diet-plan/
[7] - https://pubmed.ncbi.nlm.nih.gov/35054805/
[8] - https://emedicine.medscape.com/article/2086909-overview
[9] - https://www.americanbrainfoundation.org/neuroinflammation-and-alzheimers-disease/
[10] - https://www.scientificamerican.com/article/three-anti-inflammatory-supplements-can-really-fight-disease-according-to/
[11] - https://www.ahajournals.org/doi/10.1161/JAHA.125.047298
[12] - https://putnams.co.uk/blogs/news/sleep-and-inflammation-how-poor-rest-fuels-chronic-pain
[13] - https://pmc.ncbi.nlm.nih.gov/articles/PMC11399254
[14] - https://lifestyle.sustainability-directory.com/learn/how-long-does-it-typically-take-for-dietary-changes-to-impact-inflammatory-markers-and-mood/
[15] - https://newsroom.wakehealth.edu/news-releases/2022/07/research-reveals-brain-inflammation-associated-with-alzheimers-risk-sleep-disturbance
[16] - https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.29887
[17] - https://www.broadinstitute.org/news/researchers-identify-immune-system-mechanism-regulates-inflammation
[18] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6911017/
[19] - https://redcliffelabs.com/myhealth/lab-test/crp-normal-range-how-much-crp-level-is-dangerous-c-reactive-protein-level-chart/
[20] - https://www.ncbi.nlm.nih.gov/books/NBK441843/
[21] - https://pmc.ncbi.nlm.nih.gov/articles/PMC7122305/
[22] - https://arc-w.nihr.ac.uk/news/inflammatory-markers-explained/
[23] - https://pmc.ncbi.nlm.nih.gov/articles/PMC8001241/
[24] - https://patient.info/treatment-medication/blood-tests/blood-tests-to-detect-inflammation
[25] - https://my.clevelandclinic.org/health/articles/16037-mediterranean-diet
[26] - https://www.drlouisenewson.co.uk/knowledge/inflammation-menopause-and-hormones-whats-the-connection
[27] - https://pmc.ncbi.nlm.nih.gov/articles/PMC12265326/
[28] - https://www.verywellhealth.com/turmeric-and-fish-oil-11754659
[29] - https://news.harvard.edu/gazette/story/2023/11/new-study-explains-how-exercise-reduces-chronic-inflammation/
[30] - https://www.medicalnewstoday.com/articles/315255
[31] - https://pmc.ncbi.nlm.nih.gov/articles/PMC3629815/
[32] - https://www.sciencedirect.com/science/article/abs/pii/S144024402600006X
[33] - https://www.drlouisenewson.co.uk/knowledge/body-identical-hormones
[34] - https://thebms.org.uk/publications/consensus-statements/bioidentical-hrt/
[35] - https://www.bodylogicmd.com/blog/how-bhrt-supports-joint-health-and-reduces-chronic-pain/
[36] - https://www.vogue.com/article/anti-inflammatory-diet-digestion
[37] - https://health.clevelandclinic.org/anti-inflammatory-diet
[38] - https://www.shortform.com/books/blog/inflammation-and-menopause.html
[39] - https://nicoleapelian.com/blog/more-than-hot-flashes-the-hidden-connection-between-menopause-and-inflammation/
[40] - https://link.springer.com/article/10.1186/s12974-020-01998-9
[41] - https://www.health.harvard.edu/diseases-and-conditions/how-inflammaging-shapes-our-health
[42] - https://www.nature.com/articles/srep15224
[43] - https://www.sciencedirect.com/science/article/abs/pii/S1297319X12003119
[44] - https://pmc.ncbi.nlm.nih.gov/articles/PMC7585188/
[45] - https://pmc.ncbi.nlm.nih.gov/articles/PMC9862030/
[46] - https://www.natap.org/2007/HIV/030907_01.htm
[47] - https://scholars.houstonmethodist.org/en/publications/adipokines-inflammation-and-visceral-adiposity-across-the-menopau/
[48] - https://www.sciencedirect.com/science/article/abs/pii/S0378512224002147
[49] - https://pmc.ncbi.nlm.nih.gov/articles/PMC9379122/
[50] - https://www.sciencedirect.com/science/article/pii/S1673852724003114
[51] - https://www.nature.com/articles/s44294-024-00050-y
[52] - https://themenopausemedic.com/microbiome-and-menopause/
[53] - https://www.nia.nih.gov/news/does-cellular-senescence-hold-secrets-healthier-aging
[54] - https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1297637/full
[55] - https://www.nature.com/articles/s41413-024-00375-z
[56] - https://www.nhs.uk/conditions/rheumatoid-arthritis/symptoms/
[57] - https://www.hopkinsarthritis.org/arthritis-info/rheumatoid-arthritis/ra-symptoms/
[58] - https://www.cedars-sinai.org/health-library/diseases-and-conditions/c/chronic-fatigue-syndrome.html
[59] - https://pmc.ncbi.nlm.nih.gov/articles/PMC9914477/
[60] - https://pmc.ncbi.nlm.nih.gov/articles/PMC2885494/
[61] - https://www.birmingham.ac.uk/news-archive/2019/link-between-inflammation-and-mental-sluggishness-shown-in-new-study
[62] - https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/symptoms-causes/syc-20353315
[63] - https://nyulangone.org/news/five-inflammatory-bowel-disease-symptoms-you-should-never-ignore
[64] - https://www.webmd.com/cold-and-flu/immune-system-disorders
[65] - https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034388
[66] - https://www.jacc.org/doi/10.1016/j.jacc.2025.08.047
[67] - https://www.health.harvard.edu/heart-health/inflammation-and-heart-disease-a-smoldering-threat
[68] - https://www.acc.org/about-acc/press-releases/2020/11/02/19/00/avoiding-inflammatory-foods-can-lower-heart-disease-stroke-risk
[69] - https://www.endocrine.org/patient-engagement/endocrine-library/menopause-and-bone-loss
[70] - https://pmc.ncbi.nlm.nih.gov/articles/PMC1308846/